Astria Therapeutics (ATXS) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.01
-0.81
-0.6
-0.4

Details

Expected EPS
-0.55
Actual EPS
-0.4
Surprise EPS
0.15
Surprise Percent
+27.27%

Description

Astria Therapeutics (ATXS) has reported earnings of -0.4 per share for Q1 2023.

0 Comments

Share your thoughts